“Impact of Bulky & Liposomal Secukinumab on Lymphocytes of Psoriatic Patients, to Determine the Improvement in Bioavailability of Secukinumab Nanolipo”. 2025. American Journal of Life Science and Innovation 4 (1): 27-35. https://doi.org/10.54536/ajlsi.v4i1.3268.